This inventor holds 1 USPTO granted patent. Top assignee: Rohm Gmbh. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: The Innovations of Giuseppe Di Pascale
Introduction
Giuseppe Di Pascale is a notable inventor based in Weiterstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative approach has led to advancements that enhance the effectiveness and safety of medication delivery.
Latest Patents
Giuseppe holds a patent for an oral dosage unit form that features coating agents comprising a liquid phase, a polysaccharide that decomposes in the colon, such as locust bean gum or guar gum, and a film-forming polymer with hydrophilic groups. This unique formulation allows for coatings of high mechanical strength that are decomposed under the influence of glycosidic enzymes in the colon. His patent is a significant step forward in the design of oral dosage forms that incorporate these agents.
Career Highlights
Giuseppe Di Pascale is currently employed at Rohm GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery systems, ensuring that medications are both effective and safe for patients. With a patent portfolio that includes 1 patent, he has established himself as a key player in his field.
Collaborations
Throughout his career, Giuseppe has collaborated with several talented individuals, including Klaus Lehmann and Ottilie E Kehr-Dreher. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical technology.
Conclusion
Giuseppe Di Pascale's contributions to the field of pharmaceuticals exemplify the impact of innovation on healthcare. His work in developing advanced oral dosage forms demonstrates his commitment to improving patient outcomes through effective medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
